Loop Genomics

📍 San Jose, United States🗓 Founded 2015👥 2 employees💰 Last funded May 2016
Biotechnology🌐 loopgenomics.com
Website LinkedIn
Loop Genomics is the only hardware-free synthetic long read sequencing approach that transforms any short read sequencer into a single molecule long read sequencer. The company has developed proprietary sample prep and software that tag DNA/RNA molecules with DNA barcodes and copies and pastes those barcodes intra-molecularly throughout long molecules. Once barcodes are distributed intra-molecularly, libraries are converted into a standard short read library and sequenced on any short read sequencer. After sequencing, reads with the same barcodes are grouped together and assembled back into the longer molecules that were tagged by those barcode using Loops software. Loop sequencing is used to assemble genomes, transcriptomes or targeted amplicons from long reads, providing highly accurate, single molecule long read data for any application and leveraging your existing short read infrastructure.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Loop Genomics?
Loop Genomics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Loop Genomics last raise funding?
The most recent investment in Loop Genomics recorded on gritt.io was in May 2016.
When was Loop Genomics founded?
Loop Genomics was founded in 2015.
What industry is Loop Genomics in?
Loop Genomics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Loop Genomics based?
Loop Genomics is headquartered in San Jose, United States.